🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesGLP-1 and arterial inflammation — hsCRP and IL-6 reduction data Page 3

GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data

Dr.MetabolicMD Sun, Jun 7, 2026 at 6:29 PM 18 replies 410 viewsPage 3 of 4
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
Jun 8, 2026 at 6:23 AM#11
Dr.SurgeonPGH said:
Advanced lipoprotein testing on the lipid panel — going beyond standard lipid panel: Marker Baseline Month 8 Clinical Meaning LDL-P 1674 974 Particle…

Genuinely useful, thank you. I had the facts and not the framework. Sending this to two other people who asked me the same thing last week.

31 6MikeFit_NJ, InsuranceTom, WendyG_ATL and 28 others
Reply Quote Save Share Report
Dr.Martinez
Medical Advisor
3,891
28,456
Nov 2023
Boston, MA
Online
Jun 8, 2026 at 8:05 AM#12

From the other side of the consultation, briefly. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

30 5traveltech_sara, AttorneyGrant, DebRD_ATL and 27 others
Reply Quote Save Share Report
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
Jun 8, 2026 at 9:47 AM#13
BariatricNurseD said:
Before/after bloodwork compilation for the lipid panel — everything in one place for those who want comprehensive data: Category Marker Before After…

This is where I part company with the consensus forming above. This treats a plausible mechanism as a demonstrated one. Plausible is where you start looking, not where you stop.

29 4FDA_TrackerJim, ricardo_MIA, BrianDallas92 and 26 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.RaviCardio
VIP Member
2,890
15,678
Jan 2024
New York, NY
Jun 8, 2026 at 11:28 AM#14

The figures, for anyone assembling their own picture. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

Last edited: Jun 8, 2026 at 12:28 PM
28 3hans_munich, jason_sac26, chris_chi24 and 25 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Jun 8, 2026 at 1:10 PM#15

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. Thread quality here is what the rules are for. Keep it up.

Last edited: Jun 8, 2026 at 3:10 PM
27 2PurityPaulOR, MaxMetOK, MounjBrad and 24 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
Blood pressure reduction mechanisms on GLP-1 — natriuresis18 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register